Publications by authors named "Ivan Zimmermann"

Claim this Profile
N
Nivolumab and pembrolizumab in the treatment of metastatic melanoma: a retrospective budget impact analysis from the perspective of the Brazilian National Health System, Brazil, 2019-2022.
Ricardo Ribeiro Alves Fernandes, Keitty Regina Cordeiro de Andrade, Ivan Ricardo Zimmermann

Epidemiol Serv Saude· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget Impact of the Oncotype DX Test in Early-Stage Breast Cancer for the Brazilian Private Health Care System.
Carlos Alberto da Silva Magliano, Ivan R Zimmermann, Leandro Jonata de Carvalho Oliveira, Marcia Gisele Santos da Costa, Tomás Reinert

JCO Glob Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness assessment of liquid biopsy for early detection of lung cancer in Brazil.
Kátia Marie Senna, Ivan Ricardo Zimmermann, Márcia Gisele Santos da Costa, Bernardo Rangel Tura, José Ronyeryson Dos Santos Evangelista

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis.
Marcio Coutinho Xavier Naves, Angelica Amorim Amato, Ivan Ricardo Zimmermann, Henry Maia Peixoto

Lancet Reg Health Am· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar monoclonal antibodies for cancer treatment in adults.
Tais F Galvao, Annemeri Livinalli, Luciane C Lopes, Ivan R Zimmermann, Marcus Tolentino Silva

Cochrane Database Syst Rev· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and feasibility of a novel semi-facial respirator with chitosan nanoparticles on the incidence of SARS-CoV-2 infection in healthcare professionals: randomized controlled trial.
Aline Midori Adati Kubota, Mário Fabrício Fleury Rosa, Solange Baraldi, Janine Araújo Montefusco Vale, Joana D Arc Gonçalves da Silva, Ivan Ricardo Zimmermann

BMC Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review.
Bárbara Manuella Cardoso Sodré-Alves, Melina Mafra Toledo, Ivan Ricardo Zimmermann, Wildo Navegantes de Araújo, Noemia Urruth Leão Tavares

Rev Soc Bras Med Trop· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation-based economic evaluation of the Wolbachia method in Brazil: a cost-effective strategy for dengue control.
Ivan Ricardo Zimmermann, Ricardo Ribeiro Alves Fernandes, Márcia Gisele Santos da Costa, Márcia Pinto, Henry Maia Peixoto

Lancet Reg Health Am· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of onasemnogene abeparvovec for the treatment of patients with spinal muscular atrophy type 1: A systematic review with meta-analysis.
Brígida Dias Fernandes, Bárbara Corrêa Krug, Fernanda D'Athayde Rodrigues, Hérica Núbia Cardoso Cirilo, Stéfani Sousa Borges, Ivan Zimmermann

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Onasemnogene Abeparvovec Compared With Nusinersen and Risdiplam in Patients With Spinal Muscular Atrophy Type 1 in Brazil: Custo-Efetividade do Onasemnogeno Abeparvoveque (AVXS-101) em Comparação ao Nusinersena e Risdiplam em Pacientes com Atrofia Muscular Espinhal Tipo 1 no Brasil.
Brígida Dias Fernandes, Fernanda D'Athayde Rodrigues, Hérica Núbia Cardoso Cirilo, Stéfani Sousa Borges, Bárbara Corrêa Krug, Ivan Zimmermann

Value Health Reg Issues· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of trachoma in indigenous and non-indigenous areas, Northeastern Brazil, 2019-2021.
Daniela Vaz Ferreira Gomez, Wanessa da Silva de Almeida, Paulo Roberto Borges de Souza Junior, Maria de Fátima Costa Lopes, Expedito José de Albuquerque Luna, Ivan Ricardo Zimmermann

Rev Panam Salud Publica· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Availability of emergency contraception in large Brazilian municipalities: a guaranteed right?
Ana Carolina Gomes Pinheiro, Bárbara Manuella Cardoso Sodré Alves, Claudia Mara Pedrosa, Tiago Marques Dos Reis, Andréa Dâmaso Bertoldi, Ivan Ricardo Zimmermann

Front Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution.
Débora Silva Gonçalves, Arn Migowski, Susanne Crocamo Ventilari da Costa, Rodrigo Saar da Costa, Katia Marie Simões E Senna, Ivan Ricardo Zimmermann

Rev Bras Epidemiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer.
Laura A Barufaldi, Rita de C R de Albuquerque, Aline do Nascimento, Luís Felipe L Martins, Ivan R Zimmermann

Value Health Reg Issues· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
João M Castaldelli-Maia, Yuan-Pang Wang, Andre R Brunoni, Andre Faro, Rafael A Guimarães, Ivan R Zimmermann

Lancet Psychiatry· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Social vulnerability, survival, and hospital lethality by COVID-19 in patients aged 50 years and over: retrospective cohort of cases in Brazil in 2020 and 2021].
Ivan Lira Dos Santos, Ivan Ricardo Zimmermann, Maria Rita Donalísio, Mariana Reis Santimaria, Mauro Niskier Sanchez

Cad Saude Publica· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Utility Measurement for Economic Analysis: The Brazilian Policy.
Marisa Santos, Andrea Liborio Monteiro, Aline Navega Biz, Augusto Guerra, Helena Cramer, Ivan Zimmermann

Value Health Reg Issues· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How long does it take to translate research findings into routine healthcare practice?-the case of biological drugs for rheumatoid arthritis in Brazil.
Evandro de Oliveira Lupatini, Ivan Ricardo Zimmermann, Jorge Otávio Maia Barreto, Everton Nunes da Silva

Ann Transl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study.
Luciane C Lopes, Maribel Salas, Claudia Garcia Serpa Osorio-de-Castro, Lisiane Freitas Leal, Svetlana V Doubova, Ivan R Zimmermann

Pharmacoepidemiol Drug Saf· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

JAMA Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 as the leading cause of hospital deaths in the Brazilian public health system in 2020.
Ivan Ricardo Zimmermann, Mauro Niskier Sanchez, Layana Costa Alves, Gustavo Saraiva Frio, Fabrício Vieira Cavalcante

Int J Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in COVID-19 case-fatality rates in Brazilian public hospitals: A longitudinal cohort of 398,063 hospital admissions from 1st March to 3rd October 2020.
Ivan Ricardo Zimmermann, Mauro Niskier Sanchez, Gustavo Saraiva Frio, Layana Costa Alves, Claudia Cristina de Aguiar Pereira

PLoS One· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projection of COVID-19 intensive care hospitalizations in the Federal District, Brazil: an analysis of the impact of social distancing measures.
Ivan Zimmermann, Mauro Sanchez, Jonas Brant, Domingos Alves

Epidemiol Serv Saude· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term real-life outcomes in a georrefered cohort of acromegalic patients in Brazil.
Lara Benigno Porto, José Wilson Corrêa Rosa, João Willy Corrêa Rosa, Luiz Augusto Casulari, Ivan Ricardo Zimmermann

Endocrine· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target therapy versus dacarbazine in first-line treatment of advanced non-surgical and metastatic melanoma: budget impact analysis from the perspective of the Brazilian National Health System, 2018-2020.
Flávia de Miranda Corrêa, Renata Leborato Guerra, Ricardo Ribeiro Alves Fernandes, Mirian Carvalho de Souza, Ivan Ricardo Zimmermann

Epidemiol Serv Saude· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis